Logo image of CGX.DE

CGRE AG (CGX.DE) Stock Fundamental Analysis

Europe - FRA:CGX - DE000A0N3EU3 - Common Stock

12.9 EUR
0 (0%)
Last: 9/11/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CGX. CGX was compared to 74 industry peers in the Real Estate Management & Development industry. The financial health of CGX is average, but there are quite some concerns on its profitability. CGX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CGX had negative earnings in the past year.
CGX.DE Yearly Net Income VS EBIT VS OCF VS FCFCGX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 200K -200K -400K

1.2 Ratios

CGX has a Return On Assets (-1.22%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -1.43%, CGX is in line with its industry, outperforming 45.95% of the companies in the same industry.
Industry RankSector Rank
ROA -1.22%
ROE -1.43%
ROIC N/A
ROA(3y)1.07%
ROA(5y)N/A
ROE(3y)-2.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CGX.DE Yearly ROA, ROE, ROICCGX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

With a decent Gross Margin value of 82.90%, CGX is doing good in the industry, outperforming 78.38% of the companies in the same industry.
CGX's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CGX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.99%
GM growth 5YN/A
CGX.DE Yearly Profit, Operating, Gross MarginsCGX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 200 -200 400

More info and screens

6

2. Health

2.1 Basic Checks

CGX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CGX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, CGX has a worse debt to assets ratio.
CGX.DE Yearly Shares OutstandingCGX.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500K 1M 1.5M
CGX.DE Yearly Total Debt VS Total AssetsCGX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1M 2M 3M

2.2 Solvency

CGX has an Altman-Z score of 6.51. This indicates that CGX is financially healthy and has little risk of bankruptcy at the moment.
CGX has a better Altman-Z score (6.51) than 98.65% of its industry peers.
CGX has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
CGX has a better Debt to Equity ratio (0.15) than 81.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 6.51
ROIC/WACCN/A
WACC7.27%
CGX.DE Yearly LT Debt VS Equity VS FCFCGX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500K 1M 1.5M 2M

2.3 Liquidity

A Current Ratio of 6.80 indicates that CGX has no problem at all paying its short term obligations.
CGX has a Current ratio of 6.80. This is amongst the best in the industry. CGX outperforms 90.54% of its industry peers.
A Quick Ratio of 4.25 indicates that CGX has no problem at all paying its short term obligations.
CGX has a Quick ratio of 4.25. This is amongst the best in the industry. CGX outperforms 86.49% of its industry peers.
Industry RankSector Rank
Current Ratio 6.8
Quick Ratio 4.25
CGX.DE Yearly Current Assets VS Current LiabilitesCGX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

5

3. Growth

3.1 Past

CGX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -666.37%.
CGX shows a strong growth in Revenue. In the last year, the Revenue has grown by 109.46%.
CGX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.66% yearly.
EPS 1Y (TTM)-666.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.3%
Revenue 1Y (TTM)109.46%
Revenue growth 3Y-7.66%
Revenue growth 5YN/A
Sales Q2Q%169.72%

3.2 Future

Based on estimates for the next years, CGX will show a very strong growth in Earnings Per Share. The EPS will grow by 64.92% on average per year.
CGX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 453.79% yearly.
EPS Next Y240.09%
EPS Next 2Y105.29%
EPS Next 3Y64.92%
EPS Next 5YN/A
Revenue Next Year13722%
Revenue Next 2Y1363.23%
Revenue Next 3Y453.79%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CGX.DE Yearly Revenue VS EstimatesCGX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
CGX.DE Yearly EPS VS EstimatesCGX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CGX. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 26.07 indicates a quite expensive valuation of CGX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CGX is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, CGX is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 26.07
CGX.DE Price Earnings VS Forward Price EarningsCGX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGX.DE Per share dataCGX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

CGX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CGX's earnings are expected to grow with 64.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y105.29%
EPS Next 3Y64.92%

More info and screens

0

5. Dividend

5.1 Amount

CGX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CGRE AG

FRA:CGX (9/11/2025, 7:00:00 PM)

12.9

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.12%
Inst Owner ChangeN/A
Ins Owners6.37%
Ins Owner ChangeN/A
Market Cap77.40M
Analysts80
Price Target14.89 (15.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.07
P/S 371.76
P/FCF N/A
P/OCF N/A
P/B 1.51
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)0.49
Fwd EY3.84%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.03
BVpS8.57
TBVpS8.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.22%
ROE -1.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.9%
FCFM N/A
ROA(3y)1.07%
ROA(5y)N/A
ROE(3y)-2.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.99%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.8
Quick Ratio 4.25
Altman-Z 6.51
F-ScoreN/A
WACC7.27%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-666.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.3%
EPS Next Y240.09%
EPS Next 2Y105.29%
EPS Next 3Y64.92%
EPS Next 5YN/A
Revenue 1Y (TTM)109.46%
Revenue growth 3Y-7.66%
Revenue growth 5YN/A
Sales Q2Q%169.72%
Revenue Next Year13722%
Revenue Next 2Y1363.23%
Revenue Next 3Y453.79%
Revenue Next 5YN/A
EBIT growth 1Y-439.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22770.3%
EBIT Next 3Y544.56%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A